Tag: EMPOWER CAD

EuroPCR 2025: All-female coronary IVL trial reports positive outcomes at 30 days

Thirty-day primary endpoint results of EMPOWER CAD, the first prospective, real-world percutaneo...

EMPOWER CAD all-female IVL trial completes enrolment

Shockwave Medical has announced the completion of enrolment in EMPOWER CAD, the first prospective al...